The Ensign Group, Inc. $ENSG is Van Berkom & Associates Inc.’s 4th Largest Position

Van Berkom & Associates Inc. reduced its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 17.2% in the 1st quarter, HoldingsChannel.com reports. The fund owned 520,197 shares of the company’s stock after selling 107,831 shares during the quarter. The Ensign Group comprises approximately 3.5% of Van Berkom & Associates Inc.’s holdings, making the stock its 4th largest position. Van Berkom & Associates Inc.’s holdings in The Ensign Group were worth $104,820,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Baillie Gifford & Co. lifted its position in shares of The Ensign Group by 62.1% during the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after purchasing an additional 1,750,645 shares in the last quarter. Wasatch Advisors LP grew its holdings in shares of The Ensign Group by 6.0% in the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares in the last quarter. Geode Capital Management LLC increased its stake in The Ensign Group by 3.4% during the 4th quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock worth $261,107,000 after buying an additional 49,117 shares during the period. Price T Rowe Associates Inc. MD increased its stake in The Ensign Group by 9.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after buying an additional 118,110 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in The Ensign Group by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company’s stock worth $190,033,000 after buying an additional 5,458 shares in the last quarter. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.00% of the company’s stock.

The Ensign Group Price Performance

ENSG stock opened at $171.28 on Monday. The company’s 50 day moving average price is $165.85 and its 200 day moving average price is $184.07. The firm has a market capitalization of $10.01 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 1.68 and a beta of 0.69. The Ensign Group, Inc. has a fifty-two week low of $134.79 and a fifty-two week high of $218.00. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter in the previous year, the firm earned $1.52 earnings per share. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. On average, equities research analysts anticipate that The Ensign Group, Inc. will post 6.82 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is presently 4.23%.

Analysts Set New Price Targets

ENSG has been the subject of several recent research reports. Weiss Ratings cut shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Truist Financial cut their price objective on The Ensign Group from $215.00 to $202.00 and set a “hold” rating on the stock in a research report on Tuesday, July 14th. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $213.50.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.